• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter to the Editor: "A Meta-Analysis of the Prevalence of Cardiac Valvulopathy in Patients With Hyperprolactinemia Treated With Cabergoline".

作者信息

Caputo Carmela, Inder Warrick J

机构信息

Department of Diabetes and Endocrinology, St. Vincent's Hospital, Melbourne, Victoria, Australia.

Department of Diabetes and Endocrinology, Princess Alexandra Hospital Brisbane, and Faculty of Medicine, the University of Queensland, Brisbane, Queensland, Australia.

出版信息

J Clin Endocrinol Metab. 2019 Oct 1;104(10):4319-4320. doi: 10.1210/jc.2019-00577.

DOI:10.1210/jc.2019-00577
PMID:30933294
Abstract
摘要

相似文献

1
Letter to the Editor: "A Meta-Analysis of the Prevalence of Cardiac Valvulopathy in Patients With Hyperprolactinemia Treated With Cabergoline".致编辑的信：“卡麦角林治疗高催乳素血症患者心脏瓣膜病患病率的荟萃分析”
J Clin Endocrinol Metab. 2019 Oct 1;104(10):4319-4320. doi: 10.1210/jc.2019-00577.
2
Response to Letter to the Editor: "A Meta-Analysis of the Prevalence of Cardiac Valvulopathy in Patients With Hyperprolactinemia Treated With Cabergoline".对编辑来信的回复：“卡麦角林治疗高催乳素血症患者心脏瓣膜病患病率的荟萃分析”
J Clin Endocrinol Metab. 2019 Oct 1;104(10):4321-4322. doi: 10.1210/jc.2019-00704.
3
Cabergoline therapy and the risk of cardiac valve regurgitation in patients with hyperprolactinemia: a meta-analysis from clinical studies.卡麦角林治疗与高泌乳素血症患者心脏瓣膜反流风险：一项来自临床研究的荟萃分析
J Endocrinol Invest. 2008 Dec;31(12):1119-23. doi: 10.1007/BF03345662.
4
Prospective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemia.卡麦角林对泌乳素瘤和特发性高泌乳素血症患者瓣膜状态影响的前瞻性长期研究。
Endocrine. 2017 Jan;55(1):239-245. doi: 10.1007/s12020-016-1120-5. Epub 2016 Oct 5.
5
Prevalence of valvular heart disease in a cohort of patients taking cabergoline for management of hyperprolactinemia.在一组服用卡麦角林治疗高催乳素血症的患者中瓣膜性心脏病的患病率。
Endocr Pract. 2008 Sep;14(6):672-7. doi: 10.4158/EP.14.6.672.
6
Cabergoline use and risk of fibrosis and insufficiency of cardiac valves. Meta-analysis of observational studies.卡麦角林的使用与心脏瓣膜纤维化和功能不全风险。观察性研究的荟萃分析。
Herz. 2013 Dec;38(8):868-80. doi: 10.1007/s00059-013-3816-0. Epub 2013 Jun 8.
7
AACE/ACE Disease State Clinical Review: Dopamine Agonists for Hyperprolactinemia and the Risk of Cardiac Valve Disease.美国临床内分泌医师协会/美国内分泌学会疾病状态临床综述：多巴胺激动剂治疗高催乳素血症与心脏瓣膜病风险
Endocr Pract. 2014 Jun;20(6):608-16. doi: 10.4158/EP14148.RA.
8
Long-term low-dose cabergoline usage: Another association with cardiac valvulopathy.长期低剂量使用卡麦角林：与心脏瓣膜病的另一种关联。
Echocardiography. 2023 Jan;40(1):61-64. doi: 10.1111/echo.15506. Epub 2022 Dec 13.
9
Assessment of cardiac valve dysfunction in patients receiving cabergoline treatment for hyperprolactinaemia.评估卡麦角林治疗高泌乳素血症患者的心脏瓣膜功能障碍。
Clin Endocrinol (Oxf). 2010 Sep;73(3):369-74. doi: 10.1111/j.1365-2265.2010.03827.x. Epub 2010 Jun 9.
10
[Cabergoline in hyperprolactinemia and valvular heart disease].[卡麦角林治疗高催乳素血症与心脏瓣膜病]
Endocrinol Nutr. 2009 Oct;56(8):412-7. doi: 10.1016/S1575-0922(09)72711-1.

引用本文的文献

1
Hyperprolactinemia in Adults with Prader-Willi Syndrome.普拉德-威利综合征成人患者的高催乳素血症
J Clin Med. 2021 Aug 16;10(16):3613. doi: 10.3390/jcm10163613.